Correction: Inflammatory and tolerogenic myeloid cells determine outcome following human allergen challenge (vol 220, e20221111, 2023)

Author(s):: Voskamp, A.L.; Tak, T.; Gerdes, M.L.; Menafra, R.; Duijster, E.; Jochems, S.P. (0000-0002-4835-1032); Kielbasa, S.M. (0000-0003-2805-6535); Kormelink, T.G.; Stam, K.A.; Hengel, O.R.J. van (0000-0001-7955-7968); Jong, N.W. de; Hendriks, R.W.; Kloet, S.L. (0000-0001-9189-0640); Yazdanbakhsh, M. (0000-0002-7666-1441); Jong, E.C. de; Wijk, R.G. van; Smits, H.H. (0000-0001-9279-2890)

Published: 2023
Publication type: Article / Letter to editor

Date issued: 2023-08-18
Language: English
Publisher: ROCKEFELLER UNIV PRESS
Is part of: Journal of Experimental Medicine (2023), No. 9
hdl: 1887/4302416
doi: 10.1084/jem.2022111108162023c